YHG-26686-16928

3 vaccinations 7 coded responses 38 check-ins 7 free-text entries 1 call case

Sex: Female
Age at first dose: 46-50
ZIP prefix: 460 / IN
Registered: 2020-12-18

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Registered in v-safe
2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-18
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-08
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-08
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-09
Survey response — days 1–6 daily, dose 2
MedDRA: Limb immobilisation, Muscular weakness — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities

Free text: Unable to raise arm; muscle weakness in upper arm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-09
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-10
Survey response — days 1–6 daily, dose 2
MedDRA: Injected limb mobility decreased — Feeling: Fair · Site: Pain

Free text: Still cannot raise arm all the way.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-11
Survey response — days 1–6 daily, dose 2
MedDRA: Joint range of motion decreased — Feeling: Fair · Site: Pain

Free text: Range of motion of upper arm almost back to normal!

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-29
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-05
Survey response — day 28, dose 2
MedDRA: Injection site pain — Feeling: Good

Free text: Arm is again sore at the injection site (2nd shot was almost a month ago on 1/8/21)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-19
Survey response — day 42, dose 2
MedDRA: Injection site pain, Ophthalmic migraine — Feeling: Good

Free text: Increased ocular migraines, arm pain at site of injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-28
Dose 3 — Pfizer-BioNTech
2021-09-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-09-30
Survey response — days 1–6 daily, dose 3
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain

Free text: Swelling and tenderness of lymph nodes in R axilla (shot given in R arm)

MedDRA releases: 2024-11 · check-in free text available
2021-10-01
Survey response — days 1–6 daily, dose 3
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Headache

Free text: Swelling and tenderness of R axillary lymph nodes (recd shot in R arm)

MedDRA releases: 2024-11 · check-in free text available
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-05
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-12
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-19
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-26
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-02
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-11-09
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-28
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-03-29
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-28
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech
3	2021-09-28	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-09	priority 2/3

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-09

Systemic reaction (other): Unable to raise arm; muscle weakness in upper arm

2021-01-10

Systemic reaction (other): Still cannot raise arm all the way.

2021-01-11

Systemic reaction (other): Range of motion of upper arm almost back to normal!

Release 3 — day 28, dose 2

2021-02-05

Symptoms: Arm is again sore at the injection site (2nd shot was almost a month ago on 1/8/21)

Release 4 — day 42, dose 2

2021-02-19

Symptoms: Increased ocular migraines, arm pain at site of injection

Release 9 — days 1–6 daily, dose 3

2021-09-30

Systemic reaction (other): Swelling and tenderness of lymph nodes in R axilla (shot given in R arm)

2021-10-01

Systemic reaction (other): Swelling and tenderness of R axillary lymph nodes (recd shot in R arm)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Injection site pain	✓	✓	✓
SD	Ophthalmic migraine	✓	✓	✓
SRO	Injected limb mobility decreased	✓	✓	✓
SRO	Joint range of motion decreased	✓	✓	✓
SRO	Limb immobilisation	✓	✓	✓
SRO	Lymph node pain	·	·	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Mobility decreased	○	○	○
SRO	Muscular weakness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release